Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- COPDIndependent statistical analysis of A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- COPDIndependent statistical analysis of COPD: Oral Nutrition Supplements vs. Energy- and Protein Dense in Between Meal Snacks.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- COPE-HCVIndependent statistical analysis of Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- CopiOs® Pericardium Membrane for Localized Alveolar Ridge Augmentation: Complete Statistical AnalysisIndependent statistical analysis of CopiOs® Pericardium Membrane for Localized Alveolar Ridge Augmentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00889265).
- COPPSIndependent statistical analysis of COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04662060).
- COPPSIndependent statistical analysis of COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04662073).
- COPS-2003Independent statistical analysis of Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CoQ10Independent statistical analysis of Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CORAL-IIndependent statistical analysis of A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Coronal Mode Ultrasound Guided Hemodialysis Cannulation: Comparison With Standard Cannulation Technique: Complete Statistical AnalysisIndependent statistical analysis of Coronal Mode Ultrasound Guided Hemodialysis Cannulation: Comparison With Standard Cannulation Technique: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI): Complete Statistical AnalysisIndependent statistical analysis of Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00353795).
- Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass: Complete Statistical AnalysisIndependent statistical analysis of Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01579513).
- Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^: Complete Statistical AnalysisIndependent statistical analysis of Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01227980).
- Cortisol Response to Moderate and Deep Sedation in Children: Complete Statistical AnalysisIndependent statistical analysis of Cortisol Response to Moderate and Deep Sedation in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01265966).
- COSMOSIndependent statistical analysis of A Study Assessing Arrhythmia Mapping With a Globe-Shaped, High-Density, Multi-Electrode Mapping Catheter: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- COSMOSIndependent statistical analysis of A Study in Participants With Non-cirrhotic NASH With Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05638737).
- COSMOS-MindIndependent statistical analysis of COcoa Supplement and Multivitamin Outcomes Study for the Mind: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03035201).
- COSP-1Independent statistical analysis of Open-source Hearing Aid Platform Comparisons: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05693610).
- COSSIndependent statistical analysis of Carotid Occlusion Surgery Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00029146).
- Cost Comparison of Cardiac Magnetic Resonance Imaging (MRI) Use in Emergency Department (ED) Patients With Chest Pain: Complete Statistical AnalysisIndependent statistical analysis of Cost Comparison of Cardiac Magnetic Resonance Imaging (MRI) Use in Emergency Department (ED) Patients With Chest Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- CoTikiSIndependent statistical analysis of Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking: Complete Statistical AnalysisIndependent statistical analysis of Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- COV-BARRIERIndependent statistical analysis of A Study of Baricitinib (LY3009104) in Participants With COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04421027).
- COV-BARRIERIndependent statistical analysis of A Study of Baricitinib (LY3009104) in Children With COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05074420).
- COVACTAIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- COVETIndependent statistical analysis of Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02954159).
- COVID SAFE 2Independent statistical analysis of COVID-19 Screening Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05216627).
- COVID-19Independent statistical analysis of Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05973006).
- COVID-19Independent statistical analysis of A Study of Opaganib in Coronavirus Disease 2019 Pneumonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04414618).
- COVID-19Independent statistical analysis of Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04491994).
- COVID-19 Anosmia Study: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 Anosmia Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04495816).
- COVID-19 Booster Study in Healthy Adults in Australia: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 Booster Study in Healthy Adults in Australia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05658523).
- COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05000216).
- COVID-19 PrEP HCW HCQ Study: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 PrEP HCW HCQ Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04354870).
- COVID-19 Project ECHO in Nursing Homes: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 Project ECHO in Nursing Homes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04499391).
- COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household…
- COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05028374).
- COVIDX_EVCDAOIndependent statistical analysis of Clinical Validation of AI-Based System for Continuous Remote Monitoring of Patient Severity - Experts' Opinion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- COViNOXIndependent statistical analysis of A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- COVIPACT 2Independent statistical analysis of Psychological Care of Oncology Patients With Post-traumatic Stress in the Context of a COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- CoVPN3008Independent statistical analysis of Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- COZIIndependent statistical analysis of CBT-I or Zolpidem/Trazodone for Insomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04468776).
- CP-690-550 Ointment For Chronic Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of CP-690-550 Ointment For Chronic Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01246583).
- CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01653158).
- CP-AFOFCIndependent statistical analysis of Cerebral Palsy: Ankle Foot Orthoses - Footwear Combinations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03756571).
- CPBIndependent statistical analysis of Platelet Transfusion During Neonatal Open Heart Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03045068).
- CPEX-011Independent statistical analysis of Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- CPIIndependent statistical analysis of Knee Arthroplasty Performed With Conventional and Customized Instrumentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01124305).
- CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma: Complete Statistical AnalysisIndependent statistical analysis of CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…